Enveric Biosciences Inc vs Super Micro Computer Inc — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while Super Micro Computer Inc trades at $25.8 (market cap $17.39B). The key difference: Super Micro Computer Inc is far larger — about 3268.8× Enveric Biosciences Inc's market cap, and Super Micro Computer Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SMCI | |
|---|---|---|
Market Cap | $5.32M | $17.39B |
Sector | Health | Technology |
52-Week High | $17.40 | $60.71 |
52-Week Low | $1.28 | $20.53 |
Enterprise Value | $408.82K | $24.91B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Super Micro Computer (SMCI) trades at $25.87, down 6.44% on the day and 56% from its 52-week high, reflecting significant recent pressure. The stock shows bearish technical signals with support at $24-$26, while fundamentals reveal strong revenue growth but margin compression and cash flow concerns. Recent news highlights a Taiwan export probe, competitive pressures in AI hardware, and a sharp sector pullback.
The outlook is mixed: valuation appears attractive with a P/E of 14.15 and P/S of 0.53, and analyst consensus targets $36.71 (42% upside). However, risks are elevated from inventory build-up, cash conversion challenges, legal investigations, and intense AI server competition. The stock offers speculative value for risk-tolerant investors betting on execution improvement.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →